• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Boston Scientific (NY: BSX )

    83.62 -0.40 (-0.48%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Boston Scientific

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    NYSE:BSX may be ready to breakout.
    BOSTON SCIENTIFIC CORP (NYSE:BSX) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
    Via Chartmill
    Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return
    Via Benzinga
    $100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
    Via Benzinga
    (BSX) - Analyzing Boston Scientific's Short Interest
    Via Benzinga
    This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
    Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
    Via Benzinga
    Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest Holdings
    These two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023. 
    Via The Motley Fool
    Topics ETFs
    What 18 Analyst Ratings Have To Say About Boston Scientific
    Via Benzinga
    Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
    Via Investor Brand Network
    $100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
    Via Benzinga
    Uncovering Noteworthy Technical Analysis Findings for BOSTON SCIENTIFIC CORP (NYSE:BSX).
    In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP. 
    Via Chartmill
    Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
    Via Investor Brand Network
    Peering Into Boston Scientific's Recent Short Interest
    Via Benzinga
    3 Healthcare Stocks to Pick Up Before the Year-End Rally
    Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending 
    Via InvestorPlace
    Will Boston Scientific Corporation (BSX) Continue Further upside?
    Boston Scientific Corporation (BSX​​​​​​​) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular... 
    Via Talk Markets
    Expert Ratings for Boston Scientific
    Via Benzinga
    Could Ozempic Harm These 3 Medical Device Stocks?
    The drug is on track to cause massive competitive shifts in the healthcare sector. 
    Via The Motley Fool
    A Look Into Boston Scientific Inc's Price Over Earnings
    Via Benzinga
    $1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Looking Into Boston Scientific's Recent Short Interest
    Via Benzinga
    3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
    Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations. 
    Via InvestorPlace
    Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
    Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
    Via Investor's Business Daily
    Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
    Via AB Newswire
    Exposures Product Safety
    Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
    Via Benzinga
    Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
    S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    (BSX) - Analyzing Boston Scientific's Short Interest
    Via Benzinga
    Medical Devices Provider Boston Scientific Cardiovascular Segment Sees Traction In Q3, Company Adjusts Annual Outlook
    Boston Scientific Corp (NYSE: BSX) generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion. 
    Via Benzinga
    Boston Scientific Inches Closer To A Breakout After Eking Out A Third-Quarter Beat
    The company also raised its outlook for the full year. 
    Via Investor's Business Daily
    Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
    Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in. 
    Via Benzinga
    Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
    The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
    Via Talk Markets
    Topics Economy
    Exposures Economy
    Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
    Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.